Mika J Välimäki

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 10

Top Topics

Left Ventricular

Transcription Factor

Top Venues

Stem cell research & therapy

Journal of medicinal chemistry

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Lotta Pohjolainen, Sini M Kinnunen, Samuli Auno, Alexandros Kiriazis, Saana Pohjavaara, Julia Kari-Koskinen, Matej Zore, Mikael Jumppanen, Jari T Yli-Kauhaluoma, Virpi Talman, Heikki J Ruskoaho, Mika J Välimäki
Switching of hypertrophic signalling towards enhanced cardiomyocyte identity and maturity by a GATA4-targeted compound. Stem cell research & therapy 15 (1) (2024)
Lotta Pohjolainen, Sini M Kinnunen, Samuli Auno, Alexandros Kiriazis, Saana Pohjavaara, Julia Kari-Koskinen, Matej Zore, Mikael Jumppanen, Jari T Yli-Kauhaluoma, Virpi Talman, Heikki J Ruskoaho, Mika J Välimäki
Switching of hypertrophic signalling towards enhanced cardiomyocyte identity and maturity by a GATA4-targeted compound. Stem cell research & therapy 15 (1) (2024)
Lotta Pohjolainen, Sini M Kinnunen, Samuli Auno, Alexandros Kiriazis, Saana Pohjavaara, Julia Kari-Koskinen, Matej Zore, Mikael Jumppanen, Jari T Yli-Kauhaluoma, Virpi Talman, Heikki J Ruskoaho, Mika J Välimäki
Switching of hypertrophic signalling towards enhanced cardiomyocyte identity and maturity by a GATA4-targeted compound. Stem cell research & therapy 15 (1) (2024)
Lotta Pohjolainen, Sini M Kinnunen, Samuli Auno, Alexandros Kiriazis, Saana Pohjavaara, Julia Kari-Koskinen, Matej Zore, Mikael Jumppanen, Jari T Yli-Kauhaluoma, Virpi Talman, Heikki J Ruskoaho, Mika J Välimäki
Switching of hypertrophic signalling towards enhanced cardiomyocyte identity and maturity by a GATA4-targeted compound. Stem cell research & therapy 15 (1) (2024)
Irena Hlushchuk, Heikki J Ruskoaho, Andrii Domanskyi, Mikko Airavaara, Mika J Välimäki
Domain-Independent Inhibition of CBP/p300 Attenuates α-Synuclein Aggregation. ACS chemical neuroscience 12 (13) (2021)
S Tuuli Karhu, Sini M Kinnunen, Marja Tölli, Mika J Välimäki, Zoltán Szabó, Virpi Talman, Heikki J Ruskoaho
GATA4-targeted compound exhibits cardioprotective actions against doxorubicin-induced toxicity in vitro and in vivo: establishment of a chronic cardiotoxicity model using human iPSC-derived cardiomyocytes. Archives of toxicology 94 (6) (2020)
Mikael Jumppanen, Sini M Kinnunen, Mika J Välimäki, Virpi Talman, Samuli Auno, Tanja Bruun, Gustav Boije Af Gennäs, Henri Xhaard, Ingo B Aumüller, Heikki Ruskoaho, Jari T Yli-Kauhaluoma
Synthesis, Identification, and Structure-Activity Relationship Analysis of GATA4 and NKX2-5 Protein-Protein Interaction Modulators. Journal of medicinal chemistry 62 (17) (2019)
Mika J Välimäki, Heikki J Ruskoaho
Targeting GATA4 for cardiac repair. IUBMB life 72 (1) (2019)
Sini M Kinnunen, Marja Tölli, Mika J Välimäki, Erhe Gao, Zoltan Szabo, Jaana Rysä, Mónica P A Ferreira, Pauli Ohukainen, Raisa Serpi, Alexandra Correia, Ermei Mäkilä, Jarno J Salonen, Jouni Hirvonen, Hélder Almeida Santos, Heikki J Ruskoaho
Cardiac Actions of a Small Molecule Inhibitor Targeting GATA4-NKX2-5 Interaction. Scientific reports 8 (1) (2018)
Mika J Välimäki, Marja A Tölli, Sini M Kinnunen, Jani Aro, Raisa Serpi, Lotta Pohjolainen, Virpi Talman, Antti Poso, Heikki J Ruskoaho
Discovery of Small Molecules Targeting the Synergy of Cardiac Transcription Factors GATA4 and NKX2-5. Journal of medicinal chemistry 60 (18) (2017)